NASDAQ

Inhibrx Biosciences, Inc. (INBX)

♥ 587 Thanks from members

Live price chart, market sentiment, and community perspectives for Inhibrx Biosciences, Inc. (NASDAQ: INBX).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Inhibrx TeamLeadership: Mark P. Lappe (CEO)Holder: Institutional InvestorsHolder: Baker Bros. AdvisorsHolder: Management InsiderssdAb TherapeuticsOncology PipelineRare Disease Therapeutics#INBX#Inhibrx Biosciences#NASDAQ INBX#Biotech#Antibody Therapeutics